drugset / Trial / NCT01206166

Trial of Supplemental Parenteral Nutrition in Under and Over Weight Critically Ill Patients (TOP-UP)

NCT01206166 ↗

RandomizedParallel-groupOpen-labelPrevention

Summary

The specific aim of the proposed study is to conduct a pilot study involving 160 critically-ill lean and obese patients enrolled at 11 sites in Canada, the United States of America, Belgium and France in order to: Specific Aims * Confirm that we can achieve a clinically significant difference in calorie and protein intake between the two intervention groups. * Estimate recruitment rate i.e. number of eligible and enrolled patients per month per site. * Evaluate the safety, tolerance, and logistics around providing supplemental PN in the study population in the context of a multicenter trial, e.g. * To ensure adequate glycemic control in both groups. * To ensure that the other metabolic consequences of the feeding strategies are minimized. * To establish adequate compliance with study protocols and completion of case report forms A secondary aim of this pilot study will be: • To explore the effect of differential effects of calorie and protein delivery on muscle and mass function.

Timeline

Start
2011-06
Primary completion
2015-03
Completion
2015-07

Outcome

Outcome not reported

Stopped (Enrollment): “Low enrollment rates.”

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject OLIMEL Other / unclassified — Intravenous